Clinical Trial Update: Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Infergen (interferon alfacon-1) plus ribavirin in hepatitis C patients who partially responded to peginterferon-alfa and ribavirin; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Infergen (interferon alfacon-1)
• Ribavirin (ribavirin)

Snippet

Sponsor: Kadmon Corporation, LLC | Conditions: Hepatitis C | Phase 4 | Status: TERMINATED